Name: The neuroleptic malignant syndrome
Creator: W.M. O'Neill
Keywords: Adult, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, Metoclopramide, Vomiting, Haloperidol, Humans, Neuroleptic Malignant Syndrome, Uterine Cervical Neoplasms

descriptionPublicationkeyboard_double_arrow_right Article 01 Jul 1990 English Publisher:Elsevier BVJournal:Clinical Oncology, volume 2, pages 241-242 (issn: 0936-6555,

Authors: W.M. O'Neill;

doi: 10.1016/s0936-6555(05)80176-1

pmid: 2261422

The neuroleptic malignant syndrome

- Summary
- Subjects
- Metrics

Abstract

The neuroleptic malignant syndrome is a serious and potentially fatal complication of neuroleptic and other dopamine antagonist drugs that are commonly used in symptom control in advanced cancer. Its true incidence is underestimated. Diagnosis may be difficult as its presentation may mimic infection or advancing malignant disease.

Related Organizations

King's College Hospital NHS Foundation Trust
United Kingdom
Guy's and St Thomas' NHS Foundation Trust
United Kingdom
St Thomas' Hospital
United Kingdom

Keywords

Adult, Postoperative Complications, Metoclopramide, Vomiting, Haloperidol, Humans, Neuroleptic Malignant Syndrome, Uterine Cervical Neoplasms, Female

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	3
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average